3.2.3.0 Car­diac Au­to­nom­ic Neu­ropa­thy.

CAN is as­so­ci­at­ed with mor­tal­i­ty in­de­pen­dent­ly of other car­dio­vas­cu­lar risk fac­tors (109,110). In its early stages, CAN may be com­plete­ly asymp­tomat­ic and de­tected only by de­creased heart rate vari­abil­i­ty with deep breath­ing. Ad­vanced dis­ease may be as­so­ci­at­ed with rest­ing tachy­car­dia (>100 bpm) and or­tho­stat­ic hy­poten­sion (a fall in sys­tolic or di­as­tolic blood pres­sure by >20 mmHg or >10 mmHg, re­spec­tive­ly, upon stand­ing with­out an ap­pro­pri­ate in­crease in heart rate). CAN treat­ment is gen­er­ally fo­cused on al­le­vi­at­ing symp­toms.